崇左上臂骨折模型贵州（网络版）智能化腹部检查教学系统,天津开放式中药学辅助教学系统,济南男性人体躯干模型,拉萨静脉穿刺虚拟教学系统,长春四倍牙周病模型,河北人工牙排列实习用蜡堤,颈椎附脊髓与脊神经放大模型购买

A day after returning from the hospital amid a severe case of the coronavirus, President Donald Trump encouraged Americans to learn to live with COVID-19 in a Tuesday morning tweet — a message that was later found to be in violation of Twitter's rules on spreading disinformation about the virus."Flu season is coming up! Many people every year, sometimes over 100,000, and despite the Vaccine, die from the Flu. Are we going to close down our Country? No, we have learned to live with it, just like we are learning to live with Covid, in most populations far less lethal!!!" Trump tweeted.The CDC estimates that between 12,000 and 61,000 people have died of the flu in the U.S. each year dating back to 2010, though an estimated 100,000 people died of the flu in 1968. 777

A federal jury in Oregon on Friday acquitted an FBI agent accused of lying to authorities about whether he opened fire during the fatal shooting of LaVoy Finicum, one of the leaders of the occupation of federal property in 2016.Agent W. Joseph Astarita was acquitted of making false statements and obstruction of justice, according to a statement from the US Attorney's Office in Portland.An attorney for Astarita, David Angeli, told CNN on Friday night that the defense emphasized during the trial there were no eyewitnesses who saw Astarita fire his weapon, and there was no ballistic evidence linking shots to his weapon."We are grateful to the men and women of the jury who saw through a case that never should have been brought," a statement from Angeli and fellow defense attorney Rob Cary said.The US Attorney's Office thanked the jury for its service. "Our system of justice relies on the absolute integrity of law enforcement officials at all levels of government," US Attorney Billy J. Williams said in a statement. Williams said the three-week trial included testimony from FBI agents, state and local law enforcement officers, forensic scientists and ballistics experts. 1190

A federal judge on Friday upheld his order that the Deferred Action for Childhood Arrivals program should be fully restored, setting a 20-day deadline for the administration to do so.DC District Judge John Bates said the Trump administration still has failed to justify its proposal to end DACA, the Obama-era program that has protected from deportation nearly 800,000 young undocumented immigrants brought to the US as children.But Bates agreed to delay his ruling for 20 days to give the administration time to respond and appeal, if it chooses. 555

A man shot himself in the head in front of the White House at just before noon Saturday, a Secret Service spokesperson has told CNN."Secret Service personnel are responding to reports of a person who allegedly suffered a self-inflicted gun shot wound along the north fence line of @WhiteHouse," the Secret Service tweeted as the incident unfolded.The man approached the fence line, removed a concealed handgun and fired several rounds, none of which appear to have been aimed at the White House, a Secret Service spokesperson said. The man has since died; no one else was injured in the incident, the spokesperson said.  633

A final analysis of a COVID-19 vaccine candidate produced by Pfizer and BioNTech shows that the drug is 95% effective in preventing the coronavirus, and the companies say they hope to apply for Emergency Use Authorization within "days," the company reported Wednesday.The announcement is an improvement from an initial analysis released by the company just over a week ago that showed the drug to be 90% effective. Those results were released when it had been confirmed that 94 participants in the trial who received a shot had contracted COVID-19, and only 10% of those participants who contracted the virus had actually received the vaccine. Updated information now shows that 170 people who participated in the trial have contracted COVID-19, which crosses the threshold for final analysis. Of those participants, 162 received a placebo shot. Of the 20,000 participants who received the vaccine, just one has developed a severe case of COVID-19. The other seven people who received the vaccine and caught the virus are only experiencing mild symptoms.Pfizer also added that the vaccine has proven to be 94% efficient in older people — a welcome sign, given that the virus tends to present more severe symptoms in elderly patients.Pfizer's trial included about 40,000 participants, half of which received the vaccine, and the other half which received the placebo. The vaccine requires two shots, which need to be taken 28 days apart.The company added that there have been no safety concerns with the vaccine. In a randomized survey of 8,000 participants, only 2% reported suffering severe fatigue, and only 4% reported suffering severe headaches. Those who say they suffered side effects only experienced them briefly after vaccination.Wednesday's announcement means Pfizer is on track to shatter records for vaccine development, a process that typically takes several years.Pfizer and BioNTech already have their vaccine candidate in production, meaning it will be ready for distribution as soon as the Food and Drug Administration grants Emergency Use Authorization.Pfizer's announcement comes days after an initial analysis of a Moderna-produced vaccine was also shown to be 95% effective. Several other companies also have a COVID-19 vaccine in the works, something that health officials say is important for logistics and safety. 2347